Semliki Forest Virus-Based Expression of Recombinant GPCRs

被引:0
|
作者
Lundstrom, Kenneth [1 ]
机构
[1] PanTherapeutics, Lutry, Switzerland
关键词
PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; SINDBIS VIRUS; CELL-LINES; PHARMACOLOGICAL CHARACTERIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; 5-HT3; RECEPTOR; IN-VITRO; VECTORS;
D O I
10.1016/bs.mie.2014.11.047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to their importance as targets for drug development, rapid and consistent high-level production of G protein-coupled receptors (GPCRs) has become an essential part of drug discovery. Alphaviruses, particularly recombinant Semliki Forest virus (SFV) particles, have provided the means for expression of a number of GPCRs in a broad range of mammalian host cell lines for pharmacological characterization by determination of receptor binding activity and functional coupling to G proteins. The rapid high-titer virus particle production has made it possible to study a large number of GPCRs in parallel. Moreover, large-scale production in adherent and suspension cultures of mammalian cells has provided sufficient amounts of GPCRs for purification and subsequent structural studies. Furthermore, the high preference for neuronal delivery of SFV particles has allowed functional and localization studies of recombinant proteins in hippocampal slice cultures, in primary neurons, and in vivo.
引用
收藏
页码:331 / 350
页数:20
相关论文
共 50 条
  • [21] Expression of the murine CB2 cannabinoid receptor using a recombinant Semliki Forest virus
    Olson, JM
    Kennedy, SJ
    Cabral, GA
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (12) : 1931 - 1942
  • [22] Formation of Infectious Pancreatic Necrosis Virus–like Particles Following Expression of Segment A by Recombinant Semliki Forest Virus
    Bronagh M. McKenna
    Richard M. Fitzpatrick
    Kerry V. Phenix
    Daniel Todd
    Laurence M. Vaughan
    Gregory J. Atkins
    Marine Biotechnology, 2001, 3 : 103 - 110
  • [23] Transfection of murine and human dendritic cells with recombinant Semliki Forest virus
    Bungener, L
    Schoemaker, M
    Wilschut, J
    Daemen, T
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 99 - 99
  • [24] Expression of the nucleoprotein of the Puumala virus from the recombinant semliki forest virus replicon:: Characterization and use as a potential diagnostic tool
    Billecocq, A
    Coudrier, D
    Boué, F
    Combes, B
    Zeller, H
    Artois, M
    Bouloy, M
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (04) : 658 - 663
  • [25] Formation of infectious pancreatic necrosis virus-like particles following expression of segment A by recombinant Semliki Forest virus
    McKenna, BM
    Fitzpatrick, RM
    Phenix, KV
    Todd, D
    Vaughan, LM
    Atkins, GJ
    MARINE BIOTECHNOLOGY, 2001, 3 (02) : 103 - 110
  • [26] Induction of specific human primary immune responses to a Semliki Forest virus-based tumor vaccine in a Trimera mouse model
    Ni, B
    Gao, W
    Zhu, B
    Lin, ZH
    Jia, ZC
    Zhou, W
    Zhao, JP
    Wang, L
    Wu, YZ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (05) : 489 - 498
  • [27] Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development
    Phenix, KV
    Wark, K
    Luke, CJ
    Skinner, MA
    Smyth, JA
    Mawhinney, KA
    Todd, D
    VACCINE, 2001, 19 (23-24) : 3116 - 3123
  • [28] Quantitative rt-pcr titration of recombinant semliki forest virus used for "in vitro" heterologous protein expression
    Puglia, A. L.
    Rezende, A. G.
    Jorge, S. A. C.
    Wagner, R.
    Pereira, C. A.
    Astray, R. M.
    NEW BIOTECHNOLOGY, 2012, 29 : S166 - S167
  • [29] Modified Semliki forest virus expression vector that facilitates cloning
    Meanger, J
    Peroulis, I
    Mills, J
    BIOTECHNIQUES, 1997, 23 (03) : 432 - &